Nucleotide sequence of chicken c-myb complementary DNA and implications for myb oncogene activation

Nature
D Rosson, E P Reddy

Abstract

Avian myeloblastosis virus (AMV), like other acute transforming viruses, arose by recombination between its helper virus and host cellular sequences. The latter sequences, termed v-myb, are responsible for the oncogenic properties of the virus. AMV causes acute myeloblastic leukaemia in chickens and transforms a specific class of haematopoietic cells in vitro, but does not induce morphological transformation of cultured fibroblasts, suggesting that only a restricted target-cell population is responsive to its transforming gene product. The normal cellular counterpart of v-myb, c-myb, is highly conserved and is present in all vertebrate and some invertebrate species examined. DNA rearrangements and altered expression of the myb oncogene have been reported in mouse lymphoid tumours and human myeloid and colon tumours. The mechanism of activation of the cellular proto-oncogenes is thought to involve the structural alteration of the coding regions that result in either the synthesis of an altered gene product or the enhanced expression of a proto-oncogene caused by alterations in its regulatory elements. To distinguish between these two mechanisms, we have cloned and sequenced the chicken c-myb complementary DNA and compared it wit...Continue Reading

References

Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·Y WeinsteinE P Reddy
Jun 1, 1985·Cell·A L KatzenJ M Bishop
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·W J BoyleM A Baluda
Jan 1, 1980·Methods in Enzymology·A M Maxam, W Gilbert
May 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·W J BoyleM A Baluda
Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·G FranchiniS R Tronick
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·K AlitaloJ M Bishop
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·J V Maizel, R P Lenk

❮ Previous
Next ❯

Citations

Jul 1, 1997·Catheterization and Cardiovascular Diagnosis·M A AzrinR G McKay
Jan 1, 1987·Journal of Molecular Evolution·T Gojobori, S Yokoyama
Jan 1, 1996·International Journal of Clinical & Laboratory Research·J GolayM Introna
Oct 29, 1987·Biochemical and Biophysical Research Communications·K UchidaT Sugimura
Oct 1, 1992·Developmental Biology·Y LeónF Giraldez
Jun 1, 1990·Biochimica Et Biophysica Acta·G L Shen-Ong
Oct 27, 1988·Nature·H BiedenkappK H Klempnauer
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·B MajelloR Dalla-Favera
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·D RossonE P Reddy
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H SakuraS Ishii
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P SaikumarE P Reddy
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A SureauB Perbal
Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H DudekE P Reddy
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M VellardB Perbal
Jul 25, 1989·Nucleic Acids Research·M DvorákJ Ríman
Apr 11, 1990·Nucleic Acids Research·T OehlerK H Klempnauer
Jan 1, 1991·Annals of the New York Academy of Sciences·A M Gewirtz, B Calabretta
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C OppiE P Reddy
Jan 1, 1993·Cancer Investigation·B CalabrettaA M Gewirtz
Nov 1, 1987·Experimental Cell Research·R I Ohlsson, S B Pfeifer-Ohlsson
Jan 1, 1987·Annals of the New York Academy of Sciences·D Rosson, E P Reddy
Mar 22, 2001·Blood Cells, Molecules & Diseases·C SicurellaR G Ramsay
Jan 1, 1993·The Plant Journal : for Cell and Molecular Biology·M J LeechT L Wang
Nov 9, 1989·Nature·J FramptonT Graf
Jun 23, 1999·Oncogene·J S Lipsick, D M Wang
Apr 14, 1995·The Journal of Biological Chemistry·L H Shapiro
Feb 1, 1988·Molecular and Cellular Biology·M F ClarkeE V Prochownik
Nov 1, 1996·Molecular and Cellular Biology·H Hirai, C J Sherr
Mar 1, 1987·Journal of Virology·J S Lipsick, C E Ibanez
Aug 1, 1991·Molecular and Cellular Biology·F A GrässerJ S Lipsick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.